NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
51 hedge funds and large institutions have $9.56M invested in NeuBase Therapeutics, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
60% less call options, than puts
Call options by funds: $395K | Put options by funds: $984K
Holders
51
Holding in Top 10
–
Calls
$395K
Puts
$984K
Top Buyers
| 1 | +$259K | |
| 2 | +$144K | |
| 3 | +$63.3K | |
| 4 |
Renaissance Technologies
New York
|
+$60K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$46.6K |
Top Sellers
| 1 | -$1.18M | |
| 2 | -$340K | |
| 3 | -$255K | |
| 4 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$188K |
| 5 |
D.E. Shaw & Co
New York
|
-$167K |